Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03879616 · ClinicalTrials.gov registry record · NA
Optimizing Gastrointestinal Procedure Appointments
A NA study of Gastrointestinal Disease, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 15,974
- Enrollment target
- 1
- Study location
NCT03879616 is a NA study of Gastrointestinal Disease that has completed, run by Kaiser Permanente. The registered enrollment target is 15,974 participants, above the 134-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (11821% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03879616, a NA study of Gastrointestinal Disease, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 15,974 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will address the question: Does an "enhanced" IVR-T protocol differ in effectiveness from the standard IVR-T protocol in reducing missed appointments and late cancellations for GI endoscopy? Hypothesis: The enhanced IVR-T protocol will be more effective.
Conditions Studied
Interventions
- BEHAVIORAL An Enhanced Reminder
Study Locations (1)
Colorado
- Kaiser Permanente - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,974 participants |
| Start Date | 2019-03-08 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03879616
The ClinicalTrials.gov registry entry for NCT03879616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15,974 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (11821% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastrointestinal Disease appearing as the primary indexed condition, and to 1 intervention - of which An Enhanced Reminder is the first listed.
NCT03879616 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03879616 about?
NCT03879616 is a clinical study titled "Optimizing Gastrointestinal Procedure Appointments". This project will address the question: Does an "enhanced" IVR-T protocol differ in effectiveness from the standard IVR-T protocol in reducing missed appointments and late cancellations for GI endoscopy? Hypothesis: The enhanced IVR-T protocol will be more effective.
What is the current status of trial NCT03879616?
This trial is currently completed. It is a NA study. The enrollment target is 15,974 participants. The study started on 2019-03-08. Estimated completion is 2021-12-31.
What conditions does trial NCT03879616 study?
This clinical trial studies the following conditions: Gastrointestinal Disease.
What interventions are being tested in trial NCT03879616?
The interventions under investigation include: An Enhanced Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT03879616?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03879616 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Nursing Practices in Hospital Oncology Care
ACTIVE NOT RECRUITING · NA
-
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
COMPLETED · NA
-
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
COMPLETED · Phase 4
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.